Managing costly new drugs to support equitable access: international collaboration and patient engagement to assess value, and managed entry agreements
<b>Tarang Sharma and colleagues</b> argue for increased collaboration across public and private sectors—internationally and with patients—in drug assessment and managed entry agreements to support equitable and sustainable access to costly medicines
Authors
- Tarang Sharma (ORCID: https://orcid.org/0000-0001-6916-2604)
- Jorge Mestre-Ferrándiz (ORCID: https://orcid.org/0000-0003-0529-1321)
- Sabine Vogler (ORCID: https://orcid.org/0000-0003-4853-4397)
- Krista Kruja (ORCID: https://orcid.org/0000-0003-3130-8908)
- Christine Årdal (ORCID: https://orcid.org/0000-0002-0891-0549)
- Ruth Lopert (ORCID: https://orcid.org/0000-0002-0882-4288)
- Simone Boselli
Institutions
- Norwegian Institute of Public Health (NO)
- European Commission (BE)
- Engineering Link (Canada) (CA)
- World Health Organization Regional Office for Europe (DK)
- Gesundheit Österreich (AT)
- Act Health (AU)
- Technische Universität Berlin (DE)
- Universidad Carlos III de Madrid (ES)
- Université de Strasbourg (FR)
Publication Details
- Journal
- BMJ
- Published
- 2025-11-11
- DOI
- https://doi.org/10.1136/bmj-2025-086174
- Citations
- 3
- Primary Topic
- Health Systems, Economic Evaluations, Quality of Life
- Type
- article
- Field-Weighted Citation Impact
- 9.39